The dilemmas of prostate cancer screening

Paul R McKenzie, Brett Delahunt and James G Kench
Med J Aust 2013; 199 (9): . || doi: 10.5694/mja13.10866
Published online: 4 November 2013

To the Editor: We are concerned by conclusions drawn by Del Mar and colleagues,1 in stating that because some autopsy studies have claimed more than 50% prevalence of latent prostate cancer in men aged over 60 years, this could be considered normal, and that these latent cancers result in a high level of overdiagnosis of prostate cancer. The study cited was conducted at Wayne State University, Detroit, in the early 1990s and indeed showed that as many as 70% of African American men in that age group showed latent prostate cancer.2 However, other articles relating to these data show that the lesions were very small, on average less than 2.3 mm, and were of a very low grade, mainly with a Gleason score of 2–5.3,4

  • Paul R McKenzie1
  • Brett Delahunt2
  • James G Kench1

  • 1 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW.
  • 2 Department of Pathology and Molecular Medicine, University of Otago, Wellington, New Zealand.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.